Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Biomed Chromatogr. 2013 Mar 10;27(7):900–909. doi: 10.1002/bmc.2880

Table 3.

The pharmacokinetic parameters of 13–197 in mice and in rats after 5 mg/kg intravenous and 50 mg/kg oral doses (N=5).

PK Parameters Mice
Rat
IV dose-
5mg/kg
Oral Dose-
50mg/kg
IV dose-
5mg/kg
(Mean ± SEM
Oral dose-
50mg/kg
(Mean ± SEM)

Tmax (h) * a) 1.0 * 12.0 ± 4.0
Cmax(ng/ml) * 340.2 * 1049.5 ± 195.1
AUClast (ng.h/ml) 3848 1184 13819 ± 5693 22168 ± 5455
AUC0-∞ (ng.h/ml) 3879 1219 13848 ± 5683 22170 ± 5454
λz (1/h) 0.044 0.1623 0.087 ± 0.020 0.138 ± 0.005
t0.5(h) 15.7 4.3 9.4 ± 2.1 5.0 ± 0.18
Vβ (l/kg) 29.26 252.5 7.5 ± 2.5 21.2 ± 3.4
CL (l/hr/kg) 1.28 40.99 0.50 ± 0.11 2.96 ± 0.53
MRT0-∞ (h) 5.14 4.4 5.7 ± 1.0 14.1 ± 1.7
Vss (l/kg) 6.6 * 2.99 ± 1.06 *
% bioavailability * 3.14 * 16.03
a)

not applicable